17-63494982-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000789.4(ACE):​c.3380+512T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.508 in 151,976 control chromosomes in the GnomAD database, including 19,904 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.51 ( 19904 hom., cov: 32)

Consequence

ACE
NM_000789.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0130

Publications

25 publications found
Variant links:
Genes affected
ACE (HGNC:2707): (angiotensin I converting enzyme) This gene encodes an enzyme involved in blood pressure regulation and electrolyte balance. It catalyzes the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This angiotensin converting enzyme (ACE) also inactivates the vasodilator protein, bradykinin. Accordingly, the encoded enzyme increases blood pressure and is a drug target of ACE inhibitors, which are often prescribed to reduce blood pressure. This enzyme additionally plays a role in fertility through its ability to cleave and release GPI-anchored membrane proteins in spermatozoa. Many studies have associated the presence or absence of a 287 bp Alu repeat element in this gene with the levels of circulating enzyme. This polymorphism, as well as mutations in this gene, have been implicated in a wide variety of diseases including cardiovascular pathophysiologies, psoriasis, renal disease, stroke, and Alzheimer's disease. Regulation of the homologous ACE2 gene may be involved in progression of disease caused by several human coronaviruses, including SARS-CoV and SARS-CoV-2. Alternative splicing results in multiple transcript variants encoding both somatic (sACE) and male-specific testicular (tACE) isoforms. [provided by RefSeq, Sep 2020]
ACE Gene-Disease associations (from GenCC):
  • renal tubular dysgenesis of genetic origin
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • intracerebral hemorrhage
    Inheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.592 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACENM_000789.4 linkc.3380+512T>C intron_variant Intron 22 of 24 ENST00000290866.10 NP_000780.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACEENST00000290866.10 linkc.3380+512T>C intron_variant Intron 22 of 24 1 NM_000789.4 ENSP00000290866.4
ENSG00000264813ENST00000577647.2 linkn.1658+512T>C intron_variant Intron 11 of 30 2 ENSP00000464149.1

Frequencies

GnomAD3 genomes
AF:
0.508
AC:
77171
AN:
151858
Hom.:
19867
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.572
Gnomad AMI
AF:
0.414
Gnomad AMR
AF:
0.540
Gnomad ASJ
AF:
0.361
Gnomad EAS
AF:
0.605
Gnomad SAS
AF:
0.610
Gnomad FIN
AF:
0.458
Gnomad MID
AF:
0.339
Gnomad NFE
AF:
0.467
Gnomad OTH
AF:
0.455
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.508
AC:
77266
AN:
151976
Hom.:
19904
Cov.:
32
AF XY:
0.509
AC XY:
37763
AN XY:
74256
show subpopulations
African (AFR)
AF:
0.572
AC:
23683
AN:
41430
American (AMR)
AF:
0.541
AC:
8253
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.361
AC:
1252
AN:
3470
East Asian (EAS)
AF:
0.605
AC:
3130
AN:
5172
South Asian (SAS)
AF:
0.611
AC:
2943
AN:
4820
European-Finnish (FIN)
AF:
0.458
AC:
4845
AN:
10572
Middle Eastern (MID)
AF:
0.340
AC:
100
AN:
294
European-Non Finnish (NFE)
AF:
0.467
AC:
31710
AN:
67932
Other (OTH)
AF:
0.462
AC:
973
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1963
3927
5890
7854
9817
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
686
1372
2058
2744
3430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.484
Hom.:
49161
Bravo
AF:
0.513
Asia WGS
AF:
0.643
AC:
2235
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
5.2
DANN
Benign
0.34
PhyloP100
-0.013
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4359; hg19: chr17-61572343; API